Association of nonalcoholic fatty liver disease with QTc interval in patients with type 2 diabetes

Nutrition, Metabolism and Cardiovascular Diseases

Volumn 24, Issue 6, 2014, Pages 663-669

  Targher, Giovanni ^a   Valbusa, Filippo ^b   Bonapace, Stafano ^b   Bertolini, Lorenzo ^b   Zenari, Luciano ^b   Pichiri, Isabella ^a   Mantovani, Alessandro ^a   Zoppini, Giacomo ^a   Bonora, Enzo ^a   Barbieri, Enrico ^b   Byrne, Christopher D ^c,d  

^a UNIVERSITY OF VERONA   (Italy)

^b SACRO CUORE DON CALABRIA HOSPITAL   (Italy)

^c UNIVERSITY OF SOUTHAMPTON   (United Kingdom)

^d UNIVERSITY HOSPITAL SOUTHAMPTON NHS FOUNDATION TRUST   (United Kingdom)

Author keywords

Arrhythmias; Cardiovascular risk; Liver fat; Nonalcoholic fatty liver disease; Type 2 diabetes

Indexed keywords

ALANINE AMINOTRANSFERASE; APOLIPOPROTEIN A; ASPARTATE AMINOTRANSFERASE; C REACTIVE PROTEIN; CHOLESTEROL; DICHLOROFLUORESCEIN; GAMMA GLUTAMYLTRANSFERASE; HIGH DENSITY LIPOPROTEIN; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; LIPOPROTEIN; LOW DENSITY LIPOPROTEIN CHOLESTEROL; TRIACYLGLYCEROL;

ADULT; AGE; AGED; ALCOHOL CONSUMPTION; ARTICLE; BODY MASS; CLINICAL ASSESSMENT; CLINICAL FEATURE; COHORT ANALYSIS; DISEASE ASSOCIATION; DISEASE SEVERITY; ECHOGRAPHY; ELECTROCARDIOGRAPHY; FEMALE; HEART FUNCTION; HUMAN; HYPERTENSION; MAJOR CLINICAL STUDY; MALE; NON INSULIN DEPENDENT DIABETES MELLITUS; NONALCOHOLIC FATTY LIVER; PRIORITY JOURNAL; QT PROLONGATION; RISK FACTOR; SEX DIFFERENCE; SMOKING; ARRHYTHMIAS, CARDIAC; COMPLICATION; CROSS-SECTIONAL STUDY; DEATH, SUDDEN, CARDIAC; DIABETIC CARDIOMYOPATHIES; EPIDEMIOLOGY; ITALY; LIVER; MIDDLE AGED; OUTPATIENT DEPARTMENT; PATHOPHYSIOLOGY; SEVERITY OF ILLNESS INDEX; SIGNAL PROCESSING;

AGED; ARRHYTHMIAS, CARDIAC; COHORT STUDIES; CROSS-SECTIONAL STUDIES; DEATH, SUDDEN, CARDIAC; DIABETES MELLITUS, TYPE 2; DIABETIC CARDIOMYOPATHIES; ELECTROCARDIOGRAPHY; FEMALE; HUMANS; ITALY; LIVER; MALE; MIDDLE AGED; NON-ALCOHOLIC FATTY LIVER DISEASE; OUTPATIENT CLINICS, HOSPITAL; RISK FACTORS; SEVERITY OF ILLNESS INDEX; SIGNAL PROCESSING, COMPUTER-ASSISTED;

EID: 84901478944     PISSN: 09394753     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.numecd.2014.01.005     Document Type: Article

References (30)

1. Anstee Q.M., Targher G., Day C.P. Progression of NAFLD to diabetes mellitus, cardiovascular disease or cirrhosis. Nat Rev Gastroenterol Hepatol 2013, 10:330-344.
2. Targher G., Day C.P., Bonora E. Risk of cardiovascular disease in patients with nonalcoholic fatty liver disease. N Engl J Med 2010, 363:1341-1350.
3. Algra A., Tijssen J.G., Roelandt J.R., Pool J., Lubsen J. QTc prolongation measured by standard 12-lead electrocardiography is an independent risk factor for sudden death due to cardiac arrest. Circulation 1991, 83:1888-1894.
4. Robbins J., Nelson J.C., Rautaharju P.M., Gottdiener J.S. The association between the length of the QT interval and mortality in the Cardiovascular Health Study. Am J Med 2003, 115:689-694.
5. Okin P.M., Devereux R.B., Lee E.T., Galloway J.M., Howard B.V. Strong Heart Study. Electrocardiographic repolarization complexity and abnormality predict all-cause and cardiovascular mortality in diabetes: the Strong Heart study. Diabetes 2004, 53:434-440.
6. Luo S., Michler K., Johnston P., Macfarlane P.W. A comparison of commonly used QT correction formulae: the effect of heart rate on the QTc of normal ECGs. J Electrocardiol 2004, 37(Suppl. 1):81-90.
7. Dekker J.M., Feskens E.J., Schouten E.G., Klootwijk P., Pool J., Kromhout D. QTc duration is associated with levels of insulin and glucose intolerance. The Zutphen Elderly study. Diabetes 1996, 45:376-380.
8. Faramawi M.F., Widdman R.P., Guastat J., Rice J., Abdul Kareem M.Y. The association of the metabolic syndrome with QTc interval in NHANES III. Eur J Epidemiol 2008, 23:459-465.
9. Fraley M.A., Birchem J.A., Senkottaiyan N., Alpert M.A. Obesity and the electrocardiogram. Obes Rev 2005, 6:275-281.
10. Li X., Ren H., Xu Z.R., Liu Y.J., Yang X.P., Liu J.Q. Prevalence and risk factors of prolonged QTc interval among Chinese patients with type 2 diabetes. Exp Diabetes Res 2012, 2012:234084.
11. Spallone V., Bellavere F., Scionti L., Maule S., Quadri R., Bax G., et al. Diabetic Neuropathy Study Group of the Italian Society of Diabetology. Recommendations for the use of cardiovascular tests in diagnosing diabetic autonomic neuropathy. Nutr Metab Cardiovasc Dis 2011, 21:69-78.
12. Voulgari C., Tentolouris N., Papadogiannis D., Moyssakis I., Perrea D., Kyriaki D., et al. Increased left ventricular arrhythmogenicity in metabolic syndrome and relationship with myocardial performance, risk factors for atherosclerosis, and low-grade inflammation. Metabolism 2010, 59:159-165.
13. Veglio M., Bruno G., Borra M., Macchia G., Bargero G., D'Errico N., et al. Prevalence of increased QT interval duration and dispersion in type 2 diabetic patients and its relationship with coronary heart disease: a population-based cohort. J Intern Med 2002, 251:317-324.
14. Valbusa F., Bertolini L., Bonapace S., Zenari L., Zoppini G., Arcaro G., et al. Relation of elevated serum uric acid levels to incidence of atrial fibrillation in patients with type 2 diabetes mellitus. Am J Cardiol 2013, 112:499-504.
15. Stevens L.A., Coresh J., Greene T., Levey A.S. Assessing kidney function-measured and estimated glomerular filtration rate. N Engl J Med 2006, 354:2473-2483.
16. Mehta S.R., Thomas E.L., Bell J.D., Johnston D.G., Taylor-Robinson S.D. Non-invasive means of measuring hepatic fat content. World J Gastroenterol 2008, 14:3476-3483.
17. Bonapace S., Perseghin G., Molon G., Canali G., Bertolini L., Zoppini G., et al. Nonalcoholic fatty liver disease is associated with left ventricular diastolic dysfunction in patients with type 2 diabetes. Diabetes Care 2012, 35:389-395.
18. Vanezis A.P., Bhopal R. Validity of electrocardiographic classification of left ventricular hypertrophy across adult ethnic groups with echocardiography as a standard. J Electrocardiol 2008, 41:404-412.
19. Rijzewijk L.J., van der Meer R.W., Smit J.W., Diamant M., Bax J.J., Hammer S., et al. Myocardial steatosis is an independent predictor of diastolic dysfunction in type 2 diabetes mellitus. J Am Coll Cardiol 2008, 52:1793-1799.
20. Fox C.S., Gona P., Hoffmann U., Porter S.A., Salton C.J., Salton C.J., et al. Pericardial fat, intrathoracic fat, and measures of left ventricular structure and function: the Framingham Heart Study. Circulation 2009, 119:1586-1591.
21. Gastaldelli A., Emdin M., Conforti F., Camastra S., Ferrannini E. Insulin prolongs the QTc interval in humans. Am J Physiol Regul Integr Comp Physiol 2009, 279:R2022-2025.
22. Guo Y., Lip G.Y., Apostolakis S. Inflammation in atrial fibrillation. J Am Coll Cardiol 2012, 60:2263-2270.
23. Bharati S., Dreifus L., Bucheleres G., Molthan M., Covitz W., Isenberg H.S., et al. The conduction system in patients with a prolonged QT interval. J Am Coll Cardiol 1985, 6:1110-1119.
24. Lin Y.C., Huang J., Kan H., Castranova V., Frisbee J.C., Yu H.G. Defective calcium inactivation causes long QT in obese insulin-resistant rat. Am J Physiol Heart Circ Physiol 2012, 302:H1013-1022.
25. Fallo F., Dalla P.A., Sonino N., Lupia M., Tona F., Federspil G., et al. Non-alcoholic fatty liver disease is associated with left ventricular diastolic dysfunction in essential hypertension. Nutr Metab Cardiovasc Dis 2009, 19:646-653.
26. Hallsworth K., Hollingsworth K.G., Thoma C., Jakovljevic D., Macgowan G.A., Anstee Q.M., et al. Cardiac structure and function are altered in adults with non-alcoholic fatty liver disease. J Hepatol 2013, 58:757-762.
27. Liu Y.C., Hung C.S., Wu Y.W., Lee Y.C., Lin Y.H., Lin C., et al. Influence of non-alcoholic fatty liver disease on autonomic changes evaluated by the time domain, frequency domain, and symbolic dynamics of heart rate variability. PLoS One 2013, 8:e61803.
28. Newton J.L., Pairman J., Wilton K., Jones D.E., Day C. Fatigue and autonomic dysfunction in non-alcoholic fatty liver disease. Clin Auton Res 2009, 19:319-326.
29. Targher G., Mantovani A., Pichiri I., Rigolon R., Dauriz M., Zoppini G., et al. Non-alcoholic fatty liver disease is associated with an increased prevalence of atrial fibrillation in hospitalized patients with type 2 diabetes. Clin Sci (Lond) 2013, 125:301-309.
30. Targher G., Valbusa F., Bonapace S., Bertolini L., Zenari L., Rodella S., et al. Non-alcoholic fatty liver disease is associated with an increased incidence of atrial fibrillation in patients with type 2 diabetes. PLoS One 2013, 8:e5718.